Tumor cell proliferation suppression was confirmed with PCNA immunohistochemical staining, showing that both Ame55 and cetuximab significantly decreased proliferating A431 tumor cell amount (Figure 3(c)). This evidence concerns the gene PCNA and neoplasm.